Hydroxytyrosol: A pleiotropic polyphenol against the cardiometabolic disease spectrum

Area of Science:

• Nutritional Biochemistry
• Cardiovascular Research
• Metabolic Health

Background:

• Cardiometabolic diseases (CMDs) are a growing global health concern, involving interconnected metabolic and cardiovascular conditions.
• Current management strategies increasingly focus on comprehensive, multi-pathway approaches.
• Hydroxytyrosol (HT), a phenolic compound from olives, has demonstrated beneficial effects on metabolic syndrome, type 2 diabetes, and cardiovascular disease (CVD).

Purpose of the Study:

• To review the potential of hydroxytyrosol (HT) in interrupting the progression of cardiometabolic diseases (CMDs).
• To elucidate the molecular mechanisms underlying HT's pleiotropic effects across the CMD spectrum.
• To identify limitations and future research directions for HT in CMD management.

Main Methods:

• Literature review of studies investigating hydroxytyrosol (HT) and its effects on cardiometabolic disease pathways.
• Analysis of molecular mechanisms, including oxidative stress, inflammation, and lipid metabolism.
• Examination of HT's role from early metabolic dysfunction to advanced cardiovascular complications.

Main Results:

• Hydroxytyrosol (HT) targets multiple pathways implicated in CMDs, including oxidative stress, inflammation, and lipid metabolism.
• HT exhibits pleiotropic activity, suggesting broad applicability in managing CMDs.
• Evidence suggests HT can mitigate risks associated with metabolic syndrome, type 2 diabetes, and CVD.

Conclusions:

• Hydroxytyrosol (HT) is a promising dietary adjunct for managing cardiometabolic diseases (CMDs) due to its multifaceted protective effects.
• Further research is needed to fully understand HT's mechanisms and optimize its translational potential in clinical settings.
• HT's ability to address interconnected pathways makes it a valuable target for future therapeutic strategies.